PEPTONIC medical AB Statistics
Total Valuation
XSAT:PMED has a market cap or net worth of SEK 92.09 million. The enterprise value is 88.54 million.
| Market Cap | 92.09M |
| Enterprise Value | 88.54M |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XSAT:PMED has 1.53 billion shares outstanding.
| Current Share Class | 1.53B |
| Shares Outstanding | 1.53B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.72% |
| Owned by Institutions (%) | 24.56% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.39 |
| PB Ratio | 1.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.28 |
| EV / Sales | 6.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.09.
| Current Ratio | 0.85 |
| Quick Ratio | 0.18 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.03 |
Financial Efficiency
Return on equity (ROE) is -40.90% and return on invested capital (ROIC) is -18.26%.
| Return on Equity (ROE) | -40.90% |
| Return on Assets (ROA) | -15.69% |
| Return on Invested Capital (ROIC) | -18.26% |
| Return on Capital Employed (ROCE) | -35.22% |
| Weighted Average Cost of Capital (WACC) | 6.86% |
| Revenue Per Employee | 7.21M |
| Profits Per Employee | -10.35M |
| Employee Count | 2 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.93% in the last 52 weeks. The beta is -0.00, so XSAT:PMED's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -43.93% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 50.31 |
| Average Volume (20 Days) | 936,467 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XSAT:PMED had revenue of SEK 14.42 million and -20.70 million in losses.
| Revenue | 14.42M |
| Gross Profit | 10.16M |
| Operating Income | -17.32M |
| Pretax Income | -20.70M |
| Net Income | -20.70M |
| EBITDA | -14.43M |
| EBIT | -17.32M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 628,000 in cash and 4.48 million in debt, with a net cash position of -3.86 million or -0.00 per share.
| Cash & Cash Equivalents | 628,000 |
| Total Debt | 4.48M |
| Net Cash | -3.86M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 49.18M |
| Book Value Per Share | n/a |
| Working Capital | -1.74M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.89M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.47%, with operating and profit margins of -120.09% and -143.54%.
| Gross Margin | 70.47% |
| Operating Margin | -120.09% |
| Pretax Margin | -143.54% |
| Profit Margin | -143.54% |
| EBITDA Margin | -100.08% |
| EBIT Margin | -120.09% |
| FCF Margin | n/a |
Dividends & Yields
XSAT:PMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -22.48% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |